{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:27:30Z","timestamp":1794742050370,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272255,81472695,81773147"],"award-info":[{"award-number":["81272255,81472695,81773147"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402249"],"award-info":[{"award-number":["81402249"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2015JJ2181"],"award-info":[{"award-number":["2015JJ2181"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2013JJ3039"],"award-info":[{"award-number":["2013JJ3039"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hunan provincial scientific research innovation special key project","award":["2012TT2013"],"award-info":[{"award-number":["2012TT2013"]}]},{"DOI":"10.13039\/501100013314","name":"111 project","doi-asserted-by":"crossref","award":["111-2-12"],"award-info":[{"award-number":["111-2-12"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The project of Innovation-driven Plan of Central South University","award":["2016CX023"],"award-info":[{"award-number":["2016CX023"]}]},{"name":"Strategic Priority Research Program of Central South University","award":["ZLXD2017004"],"award-info":[{"award-number":["ZLXD2017004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-5205-9","type":"journal-article","created":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T07:07:20Z","timestamp":1546067240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas"],"prefix":"10.1186","volume":"18","author":[{"given":"Pengfei","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buqing","family":"Sai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cijun","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8712-8952","authenticated-orcid":false,"given":"Juanjuan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,29]]},"reference":[{"key":"5205_CR1","doi-asserted-by":"crossref","unstructured":"Borozan I, Zapatka M, Frappier L, Ferretti V. Analysis of Epstein-Barr virus genomes and expression profiles in gastric adenocarcinoma. J Virol. 2018;92.","DOI":"10.1128\/JVI.00330-18"},{"key":"5205_CR2","first-page":"3","volume":"5","author":"Z Luo","year":"2012","unstructured":"Luo Z, Zhang L, Li Z, Li X, Li G, Yu H, Jiang C, Dai Y, Guo X, Xiang J. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma. BMC Med Genet. 2012;5:3.","journal-title":"BMC Med Genet"},{"key":"5205_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12885-016-2253-x","volume":"16","author":"M Niu","year":"2016","unstructured":"Niu M, Gao D, Wen Q, Wei P, Pan S, Shuai C, Ma H, Xiang J, Li Z, Fan S, et al. MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma. BMC Cancer. 2016;16:218.","journal-title":"BMC Cancer"},{"key":"5205_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/j.seminoncol.2014.12.030","volume":"42","author":"E Grywalska","year":"2015","unstructured":"Grywalska E, Rolinski J. Epstein-Barr virus-associated lymphomas. Semin Oncol. 2015;42:291\u2013303.","journal-title":"Semin Oncol"},{"key":"5205_CR5","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1038\/emm.2014.105","volume":"47","author":"Q Cai","year":"2015","unstructured":"Cai Q, Chen K, Young KH. Epstein-Barr virus-positive T\/NK-cell lymphoproliferative disorders. Exp Mol Med. 2015;47:e133.","journal-title":"Exp Mol Med"},{"key":"5205_CR6","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1093\/carcin\/bgv142","volume":"36","author":"R Accardi","year":"2015","unstructured":"Accardi R, Gruffat H, Sirand C, Fusil F, Gheit T, Hernandez-Vargas H, Le Calvez-Kelm F, Traverse-Glehen A, Cosset FL, Manet E, et al. The mycotoxin aflatoxin B1 stimulates Epstein-Barr virus-induced B-cell transformation in in vitro and in vivo experimental models. Carcinogenesis. 2015;36:1440\u201351.","journal-title":"Carcinogenesis"},{"key":"5205_CR7","first-page":"1","volume-title":"In: Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","author":"SC Kenney","year":"2011","unstructured":"Kenney SC. Reactivation and lytic replication of EBV. In: AC-FG A, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. In: Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, vol. 25. Cambridge: Cambridge University Press; 2011. p. 1\u201383."},{"key":"5205_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1286-4579(00)00277-X","volume":"2","author":"K Ikuta","year":"2000","unstructured":"Ikuta K, Satoh Y, Hoshikawa Y, Sairenji T. Detection of Epstein-Barr virus in salivas and throat washings in healthy and children. Microbes Infect. 2000;2:115\u201320.","journal-title":"Microbes Infect"},{"key":"5205_CR9","doi-asserted-by":"crossref","first-page":"18999","DOI":"10.18632\/oncotarget.7967","volume":"7","author":"CC Wu","year":"2016","unstructured":"Wu CC, Fang CY, Hsu HY, Chuang HY, Cheng YJ, Chen YJ, Chou SP, Huang SY, Lin SF, Chang Y, et al. EBV reactivation as a target of luteolin to repress NPC tumorigenesis. Oncotarget. 2016;7:18999\u20139017.","journal-title":"Oncotarget"},{"key":"5205_CR10","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1182\/blood-2012-09-454694","volume":"121","author":"JA Kanakry","year":"2013","unstructured":"Kanakry JA, Li H, Gellert LL, Lemas MV, Hsieh WS, Hong F, Tan KL, Gascoyne RD, Gordon LI, Fisher RI, et al. Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large north American cooperative group trial. Blood. 2013;121:3547\u201353.","journal-title":"Blood"},{"key":"5205_CR11","doi-asserted-by":"publisher","first-page":"13360","DOI":"10.1128\/JVI.01850-12","volume":"86","author":"SR Hagemeier","year":"2012","unstructured":"Hagemeier SR, Barlow EA, Meng Q, Kenney SC. The cellular Ataxia telangiectasia-mutated kinase promotes Epstein-Barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli. J Virol. 2012;86:13360\u201370.","journal-title":"J Virol"},{"key":"5205_CR12","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1038\/sj.onc.1210324","volume":"26","author":"SA Kamranvar","year":"2007","unstructured":"Kamranvar SA, Gruhne B, Szeles A, Masucci MG. Epstein-Barr virus promotes genomic instability in Burkitt's lymphoma. Oncogene. 2007;26:5115\u201323.","journal-title":"Oncogene"},{"key":"5205_CR13","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1101\/gad.1872909","volume":"23","author":"P Mu","year":"2009","unstructured":"Mu P, Han YC, Betel D, Yao E, Squatrito M, Ogrodowski P, de Stanchina E, D'Andrea A, Sander C, Ventura A. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 2009;23:2806\u201311.","journal-title":"Genes Dev"},{"key":"5205_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/carcin\/bgs329","volume":"34","author":"Z Luo","year":"2013","unstructured":"Luo Z, Dai Y, Zhang L, Jiang C, Li Z, Yang J, McCarthy JB, She X, Zhang W, Ma J, et al. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Carcinogenesis. 2013;34:415\u201325.","journal-title":"Carcinogenesis"},{"key":"5205_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1159\/000336178","volume":"4","author":"Y Zheng","year":"2012","unstructured":"Zheng Y, Zhang W, Ye Q, Zhou Y, Xiong W, He W, Deng M, Zhou M, Guo X, Chen P, et al. Inhibition of Epstein-Barr virus infection by lactoferrin. Journal of innate immunity. 2012;4:387\u201398.","journal-title":"Journal of innate immunity"},{"key":"5205_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12879-017-2412-y","volume":"17","author":"P Cao","year":"2017","unstructured":"Cao P, Zhang M, Wang W, Dai Y, Sai B, Sun J, Wang L, Wang F, Li G, Xiang J. Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients. BMC Infect Dis. 2017;17:323.","journal-title":"BMC Infect Dis"},{"key":"5205_CR17","doi-asserted-by":"crossref","first-page":"25478","DOI":"10.18632\/oncotarget.8172","volume":"7","author":"Y Dai","year":"2016","unstructured":"Dai Y, Wang L, Tang J, Cao P, Luo Z, Sun J, Kiflu A, Sai B, Zhang M, Wang F, et al. Activation of anaphase-promoting complex by p53 induces a state of dormancy in cancer cells against chemotherapeutic stress. Oncotarget. 2016;7:25478\u201392.","journal-title":"Oncotarget"},{"key":"5205_CR18","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1073\/pnas.84.5.1332","volume":"84","author":"E Grogan","year":"1987","unstructured":"Grogan E, Jenson H, Countryman J, Heston L, Gradoville L, Miller G. Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells. Proc Natl Acad Sci U S A. 1987;84:1332\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5205_CR19","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.chom.2010.11.004","volume":"8","author":"PA Nikitin","year":"2010","unstructured":"Nikitin PA, Yan CM, Forte E, Bocedi A, Tourigny JP, White RE, Allday MJ, Patel A, Dave SS, Kim W, et al. An ATM\/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells. Cell Host Microbe. 2010;8:510\u201322.","journal-title":"Cell Host Microbe"},{"key":"5205_CR20","first-page":"167","volume":"5","author":"J Tao","year":"2011","unstructured":"Tao J, Wu D, Li P, Xu B, Lu Q, Zhang W. microRNA-18a, a member of the oncogenic miR-17-92 cluster, targets dicer and suppresses cell proliferation in bladder cancer T24 cells. Mol Med Report. 2011;5:167\u201372.","journal-title":"Mol Med Report"},{"key":"5205_CR21","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1086\/428910","volume":"191","author":"AM Moormann","year":"2005","unstructured":"Moormann AM, Chelimo K, Sumba OP, Lutzke ML, Ploutz-Snyder R, Newton D, Kazura J, Rochford R. Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis. 2005;191:1233\u20138.","journal-title":"J Infect Dis"},{"key":"5205_CR22","doi-asserted-by":"crossref","unstructured":"Chiu YF, Sugden B. Epstein-Barr Virus: The Path from Latent to Productive Infection. Annu Rev Virol. 2016;3:359\u201372.","DOI":"10.1146\/annurev-virology-110615-042358"},{"key":"5205_CR23","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1128\/JVI.79.2.1296-1307.2005","volume":"79","author":"LLL T-LD","year":"2005","unstructured":"T-LD LLL. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol. 2005;79:1296\u2013307.","journal-title":"J Virol"},{"key":"5205_CR24","doi-asserted-by":"publisher","first-page":"e1004656","DOI":"10.1371\/journal.ppat.1004656","volume":"11","author":"AM Price","year":"2015","unstructured":"Price AM, Luftig MA. To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis. PLoS Pathog. 2015;11:e1004656.","journal-title":"PLoS Pathog"},{"key":"5205_CR25","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1158\/0008-5472.CAN-07-3027","volume":"68","author":"RUH Hino","year":"2008","unstructured":"Hino RUH, Inoue Y, Shintani Y, Ushiku T, Sakatani T, Takada K, Fukayama M. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A. Cancer Res. 2008;68:1427\u201335.","journal-title":"Cancer Res"},{"key":"5205_CR26","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/jnci\/djh313","volume":"96","author":"WH Feng","year":"2004","unstructured":"Feng WH, Cohen JI, Fischer S, Li L, Sneller M, Goldbach-Mansky R, Raab-Traub N, Delecluse HJ, Kenney SC. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst. 2004;96:1691\u2013702.","journal-title":"J Natl Cancer Inst"},{"key":"5205_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2165\/00066982-200106040-00009","volume":"6","author":"H Fan","year":"2001","unstructured":"Fan H, Gulley ML. Epstein-Barr viral load measurement as a marker of EBV-related diseases. Mol Diagn. 2001;6:279\u201389.","journal-title":"Mol Diagn"},{"key":"5205_CR28","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1182\/blood.V98.4.972","volume":"98","author":"JW Esser van","year":"2001","unstructured":"van Esser JW, van der Holt B, Meijer E, Niesters HG, Trenschel R, Thijsen SF, van Loon AM, Frassoni F, Bacigalupo A, Schaefer UW, et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT. Blood. 2001;98:972\u20138.","journal-title":"Blood"},{"key":"5205_CR29","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1097\/00007890-199709270-00010","volume":"64","author":"IA Darenkov","year":"1997","unstructured":"Darenkov IA, Marcarelli MA, Basadonna GP, Friedman AL, Lorber KM, Howe JG, Crouch J, Bia MJ, Kliger AS, Lorber MI. Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy. Transplantation. 1997;64:848\u201352.","journal-title":"Transplantation"},{"key":"5205_CR30","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/bjc.2011.612","volume":"106","author":"PA Nikitin","year":"2012","unstructured":"Nikitin PA, Luftig MA. The DNA damage response in viral-induced cellular transformation. Br J Cancer. 2012;106:429\u201335.","journal-title":"Br J Cancer"},{"key":"5205_CR31","doi-asserted-by":"publisher","first-page":"24504","DOI":"10.1038\/srep24504","volume":"6","author":"D He","year":"2016","unstructured":"He D, Xiang J, Li B, Liu H. The dynamic behavior of Ect2 in response to DNA damage. Sci Rep. 2016;6:24504.","journal-title":"Sci Rep"},{"key":"5205_CR32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/path.2487","volume":"217","author":"S Bose","year":"2009","unstructured":"Bose S, Yap LF, Fung M, Starzcynski J, Saleh A, Morgan S, Dawson C, Chukwuma MB, Maina E, Buettner M, et al. The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma. J Pathol. 2009;217:345\u201352.","journal-title":"J Pathol"},{"key":"5205_CR33","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.cell.2015.07.051","volume":"162","author":"RG VKA","year":"2015","unstructured":"VKA RG, Basu U. Malaria-induced B cell genomic instability. Cell. 2015;162:697\u20138.","journal-title":"Cell"},{"key":"5205_CR34","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1038\/emboj.2012.63","volume":"31","author":"KJ Riley","year":"2012","unstructured":"Riley KJ, Rabinowitz GS, Yario TA, Luna JM, Darnell RB, Steitz JA. EBV and human microRNAs co-target oncogenic and apoptotic viral and human during latency. EMBO J. 2012;31:2207\u201321.","journal-title":"EMBO J"},{"key":"5205_CR35","doi-asserted-by":"publisher","first-page":"e1005344","DOI":"10.1371\/journal.ppat.1005344","volume":"11","author":"X Lin","year":"2015","unstructured":"Lin X, Tsai MH, Shumilov A, Poirey R, Bannert H, Middeldorp JM, Feederle R, Delecluse HJ. The Epstein-Barr virus BART miRNA cluster of the M81 strain modulates multiple functions in primary B cells. PLoS Pathog. 2015;11:e1005344.","journal-title":"PLoS Pathog"}],"updated-by":[{"DOI":"10.1186\/s12885-019-5378-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000}}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5205-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-5205-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5205-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T23:58:46Z","timestamp":1605916726000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-5205-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5205"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-5205-9","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12885-019-5378-x","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"13 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"aaaa","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research presented here has been performed in accordance with the Declaration of Helsinki and has been approved by the ethics committee of Xiangya Hospital, Central South University, China (reference number 201312484). The patients were informed about the sample collection and had signed informed consent forms.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1293"}}